Institutions / Knoll Capital Management, LLC
Knoll Capital Management, LLC
CIK 1325083 ยท Institution ยท as of Mar 31, 2026
Portfolio value
$180.17M
Positions
37
As of
Mar 31, 2026
Portfolio trend
Portfolio value
$180.17M-17.4%Positions
37+12.1%Top holdings
Mar 31, 2026View all 37 โ
| Company | Value | % of portfolio |
|---|---|---|
| Biohaven Pharmactl Hldg Co | $19.70M | 10.9% |
| Sprott physical gold Trust | $13.72M | 7.6% |
| Royal Gold Inc | $13.42M | 7.5% |
| MeiraGTX Holdings | $10.82M | 6.0% |
| Agnico Eagle Mines Ltd | $10.71M | 5.9% |
| Kinross Gold Corp | $9.77M | 5.4% |
| Aldeyra Therapeutics, Inc. | $9.25M | 5.1% |
| Seabridge Gold Inc. | $8.98M | 5.0% |
| Franco Nev Corp | $7.91M | 4.4% |
| Ssr Mining Inc.SSRM | $7.20M | 4.0% |
| Elicio Therapeutics, Inc.ELTX | $6.74M | 3.7% |
| Entera Bio Ltd | $6.47M | 3.6% |
| Nuvation Bio Inc.NUVB | $6.43M | 3.6% |
| Centerra Gold Inc | $6.39M | 3.5% |
| Pan American Silver | $5.46M | 3.0% |
| Sprott Physical silver Trust | $5.42M | 3.0% |
| Ocular Therapeutix, Inc | $5.09M | 2.8% |
| Triple Flag Precious Metals | $3.99M | 2.2% |
| Gold RTY Corp | $3.58M | 2.0% |
| Alamos Gold Inc | $2.22M | 1.2% |
| Abeona Therapeutics Inc. | $2.18M | 1.2% |
| New Pacific Metals Corp. | $2.01M | 1.1% |
| Coeur Mining, Inc. | $1.80M | 1.0% |
| iSHares US Aerospace & Defense | $1.67M | 0.9% |
| Philip Morris International Inc. | $1.65M | 0.9% |
Activity
Mar 31, 2026View full history โ
InsidersInstitutions
This fund's 13F position changes โ what it's buying and selling.| Date | Action | Company | Value | Shares ฮ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | New | 85207H104 Common stock | $13.72M | +387K | 387,055 7.61% of portfolio | medium |
| Q1 2026 as of | Exit | 05337M104 Common stock | $-12.93M | -600K -100.00% | 0 | medium |
| Q1 2026 as of | Exit | 78463V107 Common stock | $-12.68M | -32K -100.00% | 0 | medium |
| Q1 2026 as of | New | 85207K107 Common stock | $5.42M | +222K | 222,160 3.01% of portfolio | medium |
| Q1 2026 as of | Exit | 46428Q109 Common stock | $-5.15M | -80K -100.00% | 0 | medium |
| Q1 2026 as of | New | 38071H106 Common stock | $3.58M | +1.0M | 1,000,000 1.99% of portfolio | low |
| Q1 2026 as of | Trim | Altimmune Inc Common stock | $-2.96M | -962K -85.73% | 160,000 0.27% of portfolio | low |
| Q1 2026 as of | Trim | 496902404 Common stock | $-2.75M | -90K -21.95% | 320,000 5.42% of portfolio | low |
| Q1 2026 as of | Trim | 152006102 Common stock | $-2.46M | -138K -27.82% | 359,000 3.54% of portfolio | low |
| Q1 2026 as of | Add | 89679M104 Common stock | $1.95M | +56K +95.58% | 115,000 2.22% of portfolio | low |